Lisa Downs

814 citations

23 papers · 605 indexed · h-index 10

Impact in

Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment
Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment

Papers in

Pathology and Forensic Medicine 17
- Lymphoma Diagnosis and Treatment 17
Genetics 6
- Chronic Lymphocytic Leukemia Research 6

Co-authors: Stephen J. Schuster Abass Alavi Rebecca Elstrom Donald E. Tsai Jo‐Anne Vergilio Hongming Zhuang Adam Bagg Scott Y. H. Kim
Journals: Blood (9 papers)Cancer Biology & Therapy (2 papers)Journal of Clinical Oncology (2 papers)Bone Marrow Transplantation (2 papers)PharmacoEconomics (1 paper)
Partner nations: United States

In The Last Decade

Lisa Downs

23 papers receiving 593 citations

Peers

Countries citing papers authored by Lisa Downs

Since Specialization

Citations

This map shows the geographic impact of Lisa Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Downs more than expected).

Fields of papers citing papers by Lisa Downs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Downs. The network helps show where Lisa Downs may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lisa Downs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisa Downs Line = papers co-authored together Lisa Downs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective PharmacoEconomics ·Keith W. Pratz, M. A. Hovhannisyan, Jipan Xie, Lei Yin, Xiaoyu Nie, Markéta Balcarová, Dave O. Andersen, Lisa Downs, Esprit Ma	2022	11
2	Star talent: investing in high-potential employees for organizational success Industrial and Commercial Training ·Lisa Downs	2015	12
3	Changes in regulatory T-cells in responding and non-responding patients with indolent B-cell or mantle cell lymphomas during treatment with lenalidomide, dexamethasone, and rituximab. Journal of Clinical Oncology ·Nicole A. Aqui, Leah I. Leinbach, Elise A. Chong, Phelix Rufus, Jakub Svoboda, Amanda Gordon, Lisa Downs, Sunita D. Nasta, S. J. Schuster	2010	1
4	Comparison of contrast-enhanced CT, PET/CT, PET, and low-dose non-contrast enhanced CT imaging of diffuse large B-cell (DLBCL), follicular (FL), small lymphocytic/CLL (CLL/SLL), and marginal zone lymphomas (MZL). Journal of Clinical Oncology ·Elise A. Chong, Drew A. Torigian, A. Alavi, Jakub Svoboda, Sunita D. Nasta, Lisa Downs, S. J. Schuster	2010	1
5	Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab. Blood ·Tahamtan Ahmadi, Elise A. Chong, Lisa Somerville, Nicole A. Aqui, Lisa Downs, Leah I. Leinbach, Steven C. Goldstein, Sunita D. Nasta, Natan Zelewski, Tapan Maniar, Jakub Svoboda, Stephen J. Schuster	2009	1
6	Comparison of Contrast-Enhanced CT, PET/CT, PET, and Low-Dose Non-Contrast Enhanced CT Imaging of Diffuse Large B-Cell, Follicular, Small Lymphocytic/CLL, and Marginal Zone Lymphomas. Blood ·Elise A. Chong, Drew A. Torigian, Abass Alavi, Jakub Svoboda, Anthony R. Mato, S. Ogilvy, Lisa Downs, Stephen J. Schuster	2009	1
7	Marginal Zone Lymphoma Involving Subcutaneous Fat Clinical Nuclear Medicine ·Elise A. Chong, Drew A. Torigian, Anthony R. Mato, Lisa Downs, Stephen J. Schuster	2008	2
8	The Impact of Rituximab Resistance on Overall Survival Rate in Low-Grade Follicular Lymphoma Blood ·Manuel Goncalves Henriques, Elise A. Chong, Rebecca L. Olin, Sunita D. Nasta, Charalambos Andreadis, Edward A. Stadtmauer, Keno Ivan O. Matias, Lisa Downs, Stephen J. Schuster	2008	5
9	Primary cardiac lymphoma: Utility of multimodality imaging in diagnosis and management Cancer Biology & Therapy ·Anthony R. Mato, Alicia K. Morgans, Siffedine Alkandry, Adam Bagg, Eli Glatstein, Harold Litt, Lisa Downs, Elise A. Chong, Karel A. Van Cauwenberghe, Charalambos Andreadis, Stephen J. Schuster	2007	13
10	Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation Bone Marrow Transplantation ·Jakub Svoboda, Charalambos Andreadis, Rebecca Elstrom, Davis Vogel, Lisa Downs, Mahmoud Khodjet-Kesba, Selina M. Luger, David Porter, Sunita D. Nasta, Donald E. Tsai, Alison W. Loren, Don L. Siegel, Eli Glatstein, Abass Alavi, Edward A. Stadtmauer, S. Schuster	2006	68
11	Detection of Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin’s Lymphoma (HL): Observations and Implications for Post-Remission Radiologic Surveillance. Blood ·M. M. Silva, Stephen J. Schuster, Charalambos Andreadis, Lisa Downs, Laxman Das, Sunita D. Nasta	2006	5
12	Adaptive Immunotherapy with Autologous CD25-Depleted and CD3/CD28-Costimulated T-Cells Enhances Lymphocyte Recovery after Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma. Blood ·Charalambos Andreadis, Bruce L. Levine, Sunita D. Nasta, Julio Cotte, Zhaohui Zheng, Andréa Cannon, Yoshiro Miyamoto, Lisa Downs, Laxman Das, Elizabeth Veloso, Carl H. June, Stephen J. Schuster	2006	2
13	Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection Leukemia & lymphoma ·Jakub Svoboda, Charalambos Andreadis, Lisa Downs, Wallace T. Miller, Donald E. Tsai, Stephen J. Schuster	2005	24
14	Regression of pulmonary MALT lymphoma after treatment with rituximab Leukemia & lymphoma ·Elise A. Chong, Jakub Svoboda, Sindhu Cherian, Charalambos Andreadis, Lisa Downs, Hongming Zhuang, Abass Alavi, Donald E. Tsai, Stephen J. Schuster	2005	14
15	Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma Bone Marrow Transplantation ·Charalambos Andreadis, Workaferahu Ameneshewa, Davis Vogel, Jakub Svoboda, Selina M. Luger, S. A. Naumov, Donald E. Tsai, Sunita D. Nasta, Rebecca Elstrom, Steven C. Goldstein, Lisa Downs, Patricia Mangan, Nanda Novianty, V. B. WIGGLESWORTH, Phyllis A. Gimotty, Don L. Siegel, Eli Glatstein, E. Stadtmauer	2005	19
16	Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. Blood ·Jakub Svoboda, Rebecca Elstrom, Elise A. Chong, Charalambos Andreadis, S Yaniré, Selina M. Luger, David Porter, Sunita D. Nasta, Lisa Downs, Donald L. Siegel, Eli Glatstein, Abass Alavi, Edward A. Stadtmauer, Stephen J. Schuster	2005	1
17	Enhanced Marrow [18F]Fluorodeoxyglucose Uptake Related to Myeloid Hyperplasia in Hodgkin's Lymphoma Can Simulate Lymphoma Involvement in Marrow Clinical Lymphoma ·Rebecca Elstrom, Donald E. Tsai, Jo‐Anne Vergilio, Lisa Downs, Abass Alavi, Stephen J. Schuster	2004	34
18	Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma Arthritis Care & Research ·Bradley G. Somer, Donald E. Tsai, Lisa Downs, Mohamad Nasir Shafiee, Stephen J. Schuster	2003	58
19	Use of Iodine¹³¹I-Tositumomab Radioimmunotherapy in a Patient with Waldenstrom's Macroglobulinemia Leukemia & lymphoma ·Donald E. Tsai, Ivan Maillard, Lisa Downs, Abass Alavi, Sunita D. Nasta, Eli Glatstein, Stephen J. Schuster	2003	8
20	Utility of FDG-PET scanning in lymphoma by WHO classification Blood ·Rebecca Elstrom, Liang Guan, S. Cianfanelli, Z Carr, Jo‐Anne Vergilio, Hongming Zhuang, AnnaStroh, Adam Bagg, Lisa Downs, Amit K. Mehrotra, Scott Y. H. Kim, Abass Alavi, Stephen J. Schuster	2003	315

About Lisa Downs

Lisa Downs is a scholar working on Pathology and Forensic Medicine, Genetics, Hematology, Oncology and Neurology, having authored 23 papers that have together received 605 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (6 papers), Medical Imaging Techniques and Applications (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (4 papers), Acute Myeloid Leukemia Research (2 papers), MRI in cancer diagnosis (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (421 citations), Neurology (178 citations), Radiology, Nuclear Medicine and Imaging (216 citations), Oncology (158 citations) and Genetics (58 citations). Lisa Downs has collaborated with scholars based in United States. Frequent co-authors include Stephen J. Schuster, Abass Alavi, Rebecca Elstrom, Donald E. Tsai, Jo‐Anne Vergilio, Hongming Zhuang, Adam Bagg, Scott Y. H. Kim, Liang Guan and Amit K. Mehrotra. Their work appears in journals such as Blood, Cancer Biology & Therapy, Journal of Clinical Oncology, Bone Marrow Transplantation and PharmacoEconomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact